Clinical Trial Update: Phase 2 Trial of LACTIN-V in Women at High Risk of HIV Acquisition [Phase 2]

View source ↗

Summary

Phase 2 trial results for LACTIN-V in women at high risk of HIV acquisition have been posted; the study evaluated prevention of bacterial vaginosis and potentia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Vaginosis
• HIV Infection

Drugs mentioned

• Lactin-V (Lactobacillus crispatus CTV-05)

Snippet

Sponsor: University of California, San Francisco | Conditions: Bacterial Vaginosis, HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2024-08-13